CBIO
Crescent Biopharma
CBIO
CBIO
77 hedge funds and large institutions have $567M invested in Crescent Biopharma in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 81 → 77 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
77
Holding in Top 10
1
Calls
$826K
Puts
$660K
Top Buyers
| 1 | +$6.83M | |
| 2 | +$4.55M | |
| 3 | +$3.11M | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$1.71M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$1.41M |
Top Sellers
| 1 | -$4.42M | |
| 2 | -$2.58M | |
| 3 | -$1.89M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.5M |
| 5 |
Citigroup
New York
|
-$1.29M |